James Investment Research’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-950
Closed -$51K – 395
2023
Q1
$51K Sell
950
-604
-39% -$32.2K 0.01% 361
2022
Q4
$82K Buy
+1,554
New +$78.9K 0.01% 318
2017
Q2
– Sell
-2,550
Closed -$64K – 740
2017
Q1
$64K Hold
2,550
– – ﹤0.01% 516
2016
Q4
$57K Hold
2,550
– – ﹤0.01% 405
2016
Q3
$62K Buy
+2,550
New +$60.7K ﹤0.01% 389

Other funds holding IHI

James Investment Research's IHI Position: Q2 2023 in Review

James Investment Research sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 950 shares — an estimated $51K sold.

James Investment Research first reported a position in IHI in Q3 2016 and held it in 5 quarters. The position peaked at $82K in Q4 2022. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • James Investment Research reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 950 iShares US Medical Devices ETF shares in Q2 2023, an estimated $51K.
  • James Investment Research first reported a position in iShares US Medical Devices ETF in Q3 2016 and held it in 5 quarters.
  • James Investment Research's iShares US Medical Devices ETF position peaked at $82K in Q4 2022.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.